SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,038 | -12.3% | 2,480 | +100.3% | 0.00% | – |
| Q2 2023 | $58,211 | +8.6% | 1,238 | -3.1% | 0.00% | – |
| Q1 2023 | $53,625 | +21.9% | 1,278 | +10.8% | 0.00% | – |
| Q4 2022 | $43,975 | -21.5% | 1,153 | -19.6% | 0.00% | – |
| Q3 2022 | $56,000 | -6.7% | 1,434 | -23.0% | 0.00% | – |
| Q2 2022 | $60,000 | +27.7% | 1,863 | +32.5% | 0.00% | – |
| Q1 2022 | $47,000 | -33.8% | 1,406 | -15.3% | 0.00% | – |
| Q4 2021 | $71,000 | -15.5% | 1,659 | -12.0% | 0.00% | – |
| Q3 2021 | $84,000 | -5.6% | 1,885 | +19.7% | 0.00% | – |
| Q2 2021 | $89,000 | -26.4% | 1,575 | -1.9% | 0.00% | – |
| Q1 2021 | $121,000 | -54.7% | 1,605 | -48.1% | 0.00% | -100.0% |
| Q4 2020 | $267,000 | +54.3% | 3,095 | +9.1% | 0.00% | – |
| Q3 2020 | $173,000 | +355.3% | 2,836 | +213.0% | 0.00% | – |
| Q2 2020 | $38,000 | +137.5% | 906 | +62.7% | 0.00% | – |
| Q1 2020 | $16,000 | -15.8% | 557 | +114.2% | 0.00% | – |
| Q4 2019 | $19,000 | -88.8% | 260 | -78.5% | 0.00% | – |
| Q3 2019 | $170,000 | -17.1% | 1,210 | +7.8% | 0.00% | -100.0% |
| Q2 2019 | $205,000 | +22.0% | 1,122 | +6.2% | 0.00% | – |
| Q1 2019 | $168,000 | +5500.0% | 1,056 | +2475.6% | 0.00% | – |
| Q4 2018 | $3,000 | -97.5% | 41 | -95.2% | 0.00% | – |
| Q3 2018 | $119,000 | -10.5% | 846 | -0.9% | 0.00% | – |
| Q2 2018 | $133,000 | +6550.0% | 854 | +5593.3% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -50.0% | 15 | -77.9% | 0.00% | – |
| Q3 2017 | $4,000 | -77.8% | 68 | -88.0% | 0.00% | – |
| Q1 2016 | $18,000 | -74.3% | 567 | -52.8% | 0.00% | – |
| Q4 2015 | $70,000 | +75.0% | 1,201 | +29.6% | 0.00% | – |
| Q3 2015 | $40,000 | – | 927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |